汇采药 vs 药约約二部
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
汇采药
Read full descriptionHide full description
多元化产品进行融合，提供低价格，多产品服务，流程化服务，控渠道、控区域。为终端会员企业提供高品质控销产品
药约約二部
Read full descriptionHide full description
药约約二部：好医生集团旗下大健康品类专销平台
Screenshots
Verdict
汇采药 and 药约約二部 are too close to call on the numbers: across 6 compared parameters — price, update cadence, ads and in-app purchases among them — neither pulls far enough ahead to decide it. What separates them is feature set and interface, not measurable difference.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
汇采药 ships an update every 5 weeks, 药约約二部 every 6 weeks. The most recent releases landed on October 27, 2026 and November 3, 2026 respectively.
| Parameter | 汇采药 | 药约約二部 |
|---|---|---|
| Price | Free | Free |
| Update frequency | Every 5 weeks — better | Every 6 weeks |
| Ads | No | No |
| In-app purchases | No | No |
| Devices | iPhone, iPod | iPhone, iPod |
| Requires iOS | 12.0 | 12.0 |
| Further details — not scored | ||
| Size | 51 MB | 136 MB |
| Age rating | 12+ | 17+ |
| Developer | Jiangxi Huiren Pharmaceutical Co., Ltd | Chongzhou Good Doctor Cloud Medical Technology Co., Ltd. |
In-app purchases
汇采药
No in-app purchases
药约約二部
No in-app purchases
